Controlled nucleation of topological defects in the stripe domain patterns of Lateral multilayers with Perpendicular Magnetic Anisotropy: competition between magnetostatic, exchange and misfit interactions

Magnetic lateral multilayers have been fabricated on weak perpendicular magnetic anisotropy amorphous Nd-Co films in order to perform a systematic study on the conditions for controlled nucleation of topological defects within their magnetic stripe domain pattern. A lateral thickness modulation of period $w$ is defined on the nanostructured samples that, in turn, induces a lateral modulation of both magnetic stripe domain periods $\lambda$ and average in-plane magnetization component $M_{inplane}$. Depending on lateral multilayer period and in-plane applied field, thin and thick regions switch independently during in-plane magnetization reversal and domain walls are created within the in-plane magnetization configuration coupled to variable angle grain boundaries and disclinations within the magnetic stripe domain patterns. This process is mainly driven by the competition between rotatable anisotropy (that couples the magnetic stripe pattern to in-plane magnetization) and in-plane shape anisotropy induced by the periodic thickness modulation. However, as the structural period $w$ becomes comparable to magnetic stripe period $\lambda$, the nucleation of topological defects at the interfaces between thin and thick regions is hindered by a size effect and stripe domains in the different thickness regions become strongly coupled.Comment: 10 pages, 7 figures, submitted to Physical Review

Cortistain is expressed in a distinct subset of cortical interneurons

Cortistatin is a presumptive neuropeptide that shares 11 of its 14 amino acids with somatostatin. In contrast to somatostatin, administration of cortistatin into the rat brain ventricles specifically enhances slow wave sleep, apparently by antagonizing the effects of acetylcholine on cortical excitability. Here we show that preprocortistatin mRNA is expressed in a subset of GABAergic cells in the cortex and hippocampus that partially overlap with those containing somatostatin. A significant percentage of cortistatin-positive neurons is also positive for parvalbumin. In contrast, no colocalization was found between cortistatin and calretinin, cholecystokinin, or vasoactive intestinal peptide. During development there is a transient increase in cortistatin-expressing cells in the second postnatal week in all cortical areas and in the dentate gyrus. A transient expression of preprocortistatin mRNA in the hilar region at P16 is paralleled by electrophysiological changes in dentate granule cells. Together, these observations suggest mechanisms by which cortistatin may regulate cortical activity

Microscopic reversal magnetization mechanisms in CoCrPt thin films with perpendicular magnetic anisotropy: Fractal structure versus labyrinth stripe domains

The magnetization reversal of CoCrPt thin films has been examined as a function of thickness using magneto-optical Kerr effect (MOKE) microscopy and first-order reversal curves (FORC) techniques. MOKE images show differentiated magnetization reversal regimes for different film thicknesses: while the magnetic domains in 10-nm-thick CoCrPt film resemble a fractal structure, a labyrinth stripe domain configuration is observed for 20-nm-thick films. Although FORC distributions for both cases show two main features related to irreversible processes (propagation and annihilation fields) separated by a mostly flat region, this method can nonetheless distinguish which magnetization reversal process is active according to the horizontal profile of the first FORC peak, or propagation field. A single-peak FORC profile corresponds to the fractal magnetization reversal, whereas a flat-peak FORC profile corresponds to the labyrinth magnetization reversal

Microscopic reversal magnetization mechanisms in CoCrPt thin films with perpendicular magnetic anisotropy: fractal structure versus labyrinth stripe domains

Sem informaçãoThe magnetization reversal of CoCrPt thin films has been examined as a function of thickness using magneto-optical Kerr effect (MOKE) microscopy and first-order reversal curves (FORC) techniques. MOKE images show differentiated magnetization reversal regimes for different film thicknesses: while the magnetic domains in 10-nm-thick CoCrPt film resemble a fractal structure, a labyrinth stripe domain configuration is observed for 20-nm-thick films. Although FORC distributions for both cases show two main features related to irreversible processes (propagation and annihilation fields) separated by a mostly flat region, this method can nonetheless distinguish which magnetization reversal process is active according to the horizontal profile of the first FORC peak, or propagation field. A single-peak FORC profile corresponds to the fractal magnetization reversal, whereas a flat-peak FORC profile corresponds to the labyrinth magnetization reversal.961815Sem informaçãoSem informaçãoSem informaçãoThis work was supported by Spanish Grants No. AEI FIS2013-45469 and No. AEI FIS2016-76058, and UE FEDER “Una manera de hacer Europa”, the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement No. 734801. D.N. thanks Fundaçao para a Ciência e Tecnologia (Contract No. IF/01191/2013) for financial support

Exchange-bias phenomenon: The role of the ferromagnetic spin strucutre

The exchange bias of antiferromagnetic-ferromagnetic (AFM-FM) bilayers is found to be strongly dependent on the ferromagnetic spin configuration. The widely accepted inverse proportionality of the exchange bias field with the ferromagnetic thickness is broken in FM layers thinner than the FM correlation length. Moreover, an anomalous thermal dependence of both exchange bias field and coercivity is also found. A model based on springlike domain walls parallel to the AFM-FM interface quantitatively accounts for the experimental results and, in particular, for the deviation from the inverse proportionality law. These results reveal the active role the ferromagnetic spin structure plays in AFM-FM hybrids which leads to a new paradigm of the exchange bias phenomenon

Imaging the Kirkendall effect in pyrite (FeS2) thin films: cross-sectional microstructure and chemical features

This investigation provides novel data on the structure and chemical composition of pyrite thin films and new hints concerning their formation mechanism. From TEM-HAADF data, it has been found that the films are composed of two different layers: one is very compact and the other one is quite porous with many voids separating a few groups of grains. This porous layer is always in direct contact with the substrate, and its thickness is quite similar to that of the original Fe film. The average size of pyrite grains is equal in both layers, what suggests that the same process is responsible for their formation. Concentration profiles of sulfur, iron and some impurities (mainly sodium and oxygen from the glass substrate) through both layers are given in this work, and thus chemical inhomogeneities of the films are proved by the obtained stoichiometric ratios (S/Fe). Moreover, Na from sodalime glass substrates mainly accumulates at the pyrite grain boundaries and barely dopes them. The obtained results support the hypothesis that the iron sulfuration process essentially induces the diffusion of iron atoms, what leads to the porous layer formation as a manifestation of the Kirkendall Effect. Therefore, it seems that the same mechanisms that operate in the synthesis of surface hollow structures at the nanoscale are also active in the formation of pyrite thin films ranging from several tens to hundreds of nanometersMembers of MIRE Group acknowledge the financial support of the Spanish MICINN under project RTI2018-099794-B-I00. E. Flores acknowledges the intramural CSIC project 2D-MeSes funding and the service from the MiNa Laboratory at IMN, and funding from CM (project SpaceTec, S2013/ICE2822), MINECO (project CSIC13-4E1794) and EU (FEDER,FSE). Financial support through the project UMA18-FEDERJA-041 is gratefully acknowledge

Tuning topological defects in magnetic stripe domains of lateral multilayers with perpendicular magnetic anisotropy

Resumen del póster presentado a la VIII Edición de la Reunión Bienal del Grupo Especializado de Física del Estado Sólido de la Real Sociedad Española de Física celebrada del en Ciudad Real del 22 al 24 de enero de 2014.Peer Reviewe

Altered versican cleavage in ADAMTS5 deficient mice : a novel etiology of myxomatous valve disease

AbstractIn fetal valve maturation the mechanisms by which the relatively homogeneous proteoglycan-rich extracellular matrix (ECM) of endocardial cushions is replaced by a specialized and stratified ECM found in mature valves are not understood. Therefore, we reasoned that uncovering proteases critical for ‘remodeling’ the proteoglycan rich (extracellular matrix) ECM may elucidate novel mechanisms of valve development. We have determined that mice deficient in ADAMTS5, (A Disintegrin-like And Metalloprotease domain with ThromboSpondin-type 1 motifs) which we demonstrated is expressed predominantly by valvular endocardium during cardiac valve maturation, exhibited enlarged valves. ADAMTS5 deficient valves displayed a reduction in cleavage of its substrate versican, a critical cardiac proteoglycan. In vivo reduction of versican, in Adamts5−/− mice, achieved through Vcan heterozygosity, substantially rescued the valve anomalies. An increase in BMP2 immunolocalization, Sox9 expression and mesenchymal cell proliferation were observed in Adamts5−/− valve mesenchyme and correlated with expansion of the spongiosa (proteoglycan-rich) region in Adamts5−/− valve cusps. Furthermore, these data suggest that ECM remodeling via ADAMTS5 is required for endocardial to mesenchymal signaling in late fetal valve development. Although adult Adamts5−/− mice are viable they do not recover from developmental valve anomalies and have myxomatous cardiac valves with 100% penetrance. Since the accumulation of proteoglycans is a hallmark of myxomatous valve disease, based on these data we hypothesize that a lack of versican cleavage during fetal valve development may be a potential etiology of adult myxomatous valve disease

Sobrevida, eficacia y seguridad de Golimumab en pacientes con Artritis Reumatoidea y Espondiloartritis: datos de una cohorte argentina

Objetivos: golimumab ha sido aprobado para el tratamiento de pacientes con artritis reumatoidea (AR), artritis psoriásica (APs) y espondiloartritis axial. Sin embargo, los datos provenientes de nuestra región son escasos. El objetivo de este estudio fue evaluar la eficacia, seguridad y sobrevida acumulada de golimumab en pacientes de la vida real con AR, APs y espondilitis anquilosante (EA) de diferentes centros de Argentina. Material y métodos: se llevó a cabo un estudio longitudinal, en el que se incluyeron pacientes consecutivos mayores de 18 años con diagnóstico de AR (criterios ACR/EULAR 2010), APs (critertios CASPAR) y Espax (criterios ASAS 2009), que hayan iniciado tratamiento con golimumab de acuerdo a la indicación médica. Se obtuvieron los datos por revisión de historias clínicas. Se consignaron características sociodemográficas, clínicas, comorbilidades y tratamientos previos. Con respecto al golimumab, se registraron fecha de inicio, vía de administración y tratamientos concomitantes. Se determinó la actividad de la enfermedad mediante DAS28 en el caso de la AR, por DAPSA y MDA para APs y por BASDAI en el caso de Espax. Se consignó la presencia de eventos adversos (EA). En el caso de suspensión del tratamiento, se identificaron la fecha y motivo del mismo. Los pacientes fueron seguidos hasta la suspensión del golimumab, pérdida de seguimiento, muerte, o finalización del estudio (30 de noviembre de 2020). Resultados: se incluyeron 182 pacientes, 116 con diagnóstico de AR, 30 con APs y 36 con Espax. La mayoría de ellos (70.9%) eran mujeres con una edad mediana (m) de 55 años (RIC 43.8-64) y una duración de la enfermedad m de 7 años (RIC 4-12.7) al inicio del tratamiento. El 34.6% de los mismos habían recibido al menos una droga modificadora de la enfermedad (DME) biológica (-b) o sintética dirigida (-sd) previamente. El seguimiento total fue de 318.1 pacientes/año. El tratamiento con golimumab mostró mejoría clínica en los tres grupos de pacientes. La incidencia de eventos adversos fue de 6.6 por 100 pacientes/año, siendo las infecciones las más frecuentes. Durante el seguimiento, 50 pacientes (27.5%) suspendieron golimumab, la causa más frecuente fue el fracaso del tratamiento (68%), seguida de la falta de cobertura (16%) y el desarrollo de eventos adversos (10%). La persistencia de golimumab fue del 76% y 68% a los 12 y 24 meses, respectivamente. Se registró una sobrevida de 50.2 meses (IC 95% 44.4-55.9). Los pacientes que habían recibido tratamiento previo con DME-b y/o -sd mostraron una menor sobrevida (HR 2.4, IC 95% 1.3-4.4). Conclusiones: el tratamiento con golimumab en pacientes de la vida real en Argentina ha demostrado una buena eficacia y seguridad. La sobrevida del fármaco fue de más de 4 años y casi el 80% seguía usando golimumab después de un año. El tratamiento previo con otros DME-b o -sd se asoció con una menor sobrevida al tratamiento